Roche received expanded approval from the Food and Drug Administration for a test to diagnose breast cancer. The pharmaceutical company said Monday that the FDA approved the PATHWAY HER2 (4B5) test ...
(Reuters) - The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in ...
SCAMMERS OFTEN TARGET OLDER CONSUMERS. AND ACCORDING TO THE LATEST SCAM REPORT FROM THE FEDERAL TRADE COMMISSION, SCAMMERS ...
Don’t offer Devin Roche warm bread with butter and jam. If he’s around, don’t raise a glass and wish the bride and groom well ...
“This process can be likened to a bottle of sparkling water containing dissolved volatiles that exolve when the bottle is ...
After AstraZeneca and Daiichi Sankyo made waves in June with eye-opening results for Enhertu in a combination treatment for a ...
FDA expands labels for Roche's PATHWAY HER2 (4B5) test* and VENTANA HER2 Dual ISH DNA Probe Cocktail, which can now be used ...
Naples, December 15, 2025 The Complex Operative Unit of Ophthalmology at Monaldi Hospital in Naples wins the 'Roche for ...
The Kent State women's basketball team rewrote the record book with a 117-37 victory during the annual Education Day ...
Tolebrutinib was one of three oral BTK inhibitors that Sanofi acquired as part of its $3.7 billion buyout of Principia ...
Sanofi’s multiple sclerosis hopeful tolebrutinib faced dual setbacks on Monday, with a late-stage failure in one form of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback